Cargando…

Current status and prospects of plant genome editing in Australia

Plant genome editing, particularly CRISPR-Cas biotechnologies, has rapidly evolved and drawn enormous attention all around the world in the last decade. The cutting-edge technologies have had substantial impact on precise genome editing for manipulating gene expression, stacking gene mutations, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yan, Restall, Jemma, Crisp, Peter, Godwin, Ian, Liu, Guoquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143062/
https://www.ncbi.nlm.nih.gov/pubmed/34054265
http://dx.doi.org/10.1007/s11627-021-10188-y
_version_ 1783696677376360448
author Zhang, Yan
Restall, Jemma
Crisp, Peter
Godwin, Ian
Liu, Guoquan
author_facet Zhang, Yan
Restall, Jemma
Crisp, Peter
Godwin, Ian
Liu, Guoquan
author_sort Zhang, Yan
collection PubMed
description Plant genome editing, particularly CRISPR-Cas biotechnologies, has rapidly evolved and drawn enormous attention all around the world in the last decade. The cutting-edge technologies have had substantial impact on precise genome editing for manipulating gene expression, stacking gene mutations, and improving crop agronomic traits. Following the global trends, investigations on CRISPR-Cas have been thriving in Australia, especially in agriculture sciences. Importantly, CRISPR-edited plants, classified as SDN-1 organisms (SDN: site-directed nuclease), have been given a green light in Australia, with regulatory bodies indicating they will not be classified as a genetically modified organism (GMO) if no foreign DNA is present in an edited plant. As a result, genome-edited products would not attract the onerous regulation required for the introduction of a GMO, which could mean more rapid deployment of new varieties and products that could be traded freely in Australia, and potentially to export markets. In the present review, we discuss the current status and prospects of plant genome editing in Australia by highlighting several species of interest. Using these species as case studies, we discuss the priorities and potential of plant genome editing, as well as the remaining challenges.
format Online
Article
Text
id pubmed-8143062
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-81430622021-05-25 Current status and prospects of plant genome editing in Australia Zhang, Yan Restall, Jemma Crisp, Peter Godwin, Ian Liu, Guoquan In Vitro Cell Dev Biol Plant Special Issue on Genome Editing Plant genome editing, particularly CRISPR-Cas biotechnologies, has rapidly evolved and drawn enormous attention all around the world in the last decade. The cutting-edge technologies have had substantial impact on precise genome editing for manipulating gene expression, stacking gene mutations, and improving crop agronomic traits. Following the global trends, investigations on CRISPR-Cas have been thriving in Australia, especially in agriculture sciences. Importantly, CRISPR-edited plants, classified as SDN-1 organisms (SDN: site-directed nuclease), have been given a green light in Australia, with regulatory bodies indicating they will not be classified as a genetically modified organism (GMO) if no foreign DNA is present in an edited plant. As a result, genome-edited products would not attract the onerous regulation required for the introduction of a GMO, which could mean more rapid deployment of new varieties and products that could be traded freely in Australia, and potentially to export markets. In the present review, we discuss the current status and prospects of plant genome editing in Australia by highlighting several species of interest. Using these species as case studies, we discuss the priorities and potential of plant genome editing, as well as the remaining challenges. Springer US 2021-05-24 2021 /pmc/articles/PMC8143062/ /pubmed/34054265 http://dx.doi.org/10.1007/s11627-021-10188-y Text en © The Society for In Vitro Biology 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Special Issue on Genome Editing
Zhang, Yan
Restall, Jemma
Crisp, Peter
Godwin, Ian
Liu, Guoquan
Current status and prospects of plant genome editing in Australia
title Current status and prospects of plant genome editing in Australia
title_full Current status and prospects of plant genome editing in Australia
title_fullStr Current status and prospects of plant genome editing in Australia
title_full_unstemmed Current status and prospects of plant genome editing in Australia
title_short Current status and prospects of plant genome editing in Australia
title_sort current status and prospects of plant genome editing in australia
topic Special Issue on Genome Editing
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143062/
https://www.ncbi.nlm.nih.gov/pubmed/34054265
http://dx.doi.org/10.1007/s11627-021-10188-y
work_keys_str_mv AT zhangyan currentstatusandprospectsofplantgenomeeditinginaustralia
AT restalljemma currentstatusandprospectsofplantgenomeeditinginaustralia
AT crisppeter currentstatusandprospectsofplantgenomeeditinginaustralia
AT godwinian currentstatusandprospectsofplantgenomeeditinginaustralia
AT liuguoquan currentstatusandprospectsofplantgenomeeditinginaustralia